Growth bar in Microbiology Automated industry increases as new technology emerge

Research Beam new report is a seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

Save Upto 15% on this Report @ https://www.researchbeam.com/world-microbiology-automated-supplier-shares-and-strategies-country-segment-forecasts-technology-trends-instrumentation-review-molecular-diagnostics-microbial-identification-antibiotic-susceptibility-blood-culture-urine-screening-immunodiagnostics-market/purchase-enquiry

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Worldwide Market Overview

- Estimated universe of laboratories performing microbiology testing by country.
- Specimen, test volume and sales forecasts by country.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation Analysis

- Sales and market shares for major suppliers by individual test and country.
- Volume and sales forecasts for over 100 infectious disease

assays by individual test and country.

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
- Review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Specimen Types

- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva

Applications

- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized,

microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

- The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Get the sample PDF Brochure of market study @ https://www.researchbeam.com/world-microbiology-automated-supplier-shares-and-strategies-country-segment-forecasts-technology-trends-instrumentation-review-molecular-diagnostics-microbial-identification-antibiotic-susceptibility-blood-culture-urine-screening-immunodiagnostics-market/request-sample

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
- Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
- The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Biotest, CellMark Forensics/LabCorp, Cepheid, Decode Genetics, Diadexus, Diamedix, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Illumina, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Contains 821 pages and 371 tables

Contact Us

5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Toll Free: +1 (800) 910-6452
Int'l: +1-971-202-1575
help@researchbeam.com

About Us

It is crucial for market players to take leaps strategically and update themselves with recent trends, opportunities, and emerging investment pockets. We, at “Research Beam”, adhere to these factors and offer a wide range of reports that are detailed and enable our clients to achieve their goals with long term planning coupled with competitive advantage.

Our database includes a broad array of various market reports from numerous publishers across the globe. These reports of several market categories and sub-categories help our clients to find the exact report they are looking for. We are instrumental to provide quantitative and qualitative insights in their area of interest and bring reports from various publishers under one umbrella to save their time and money. Our clients across the world are gaining profits from the information given in the reports sourced by us.

This release was published on openPR.